Trazodone Compounding Legal Status: What Patients and Prescribers Need to Know
A complete guide to trazodone's FDA approval history, compounding legal status, labeling requirements, and safety data for telehealth prescribers and patients.
Trazodone: Regulatory History
7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
7articles
3topic areas covered
Jan 15, 2025latest review
Trazodone: Regulatory History library
Showing 7 of 7 clinical reviews.
Trazodone FAERS Safety Signals: What Post-Market Surveillance Data Shows
A clinical review of trazodone adverse event reports in the FDA FAERS database, covering priapism, cardiac signals, serotonin syndrome, falls, and hepatotoxicity.
Trazodone FDA Approval History: Label, Safety, and Regulatory Timeline
A complete regulatory history of trazodone: original FDA approval, label updates, black-box warnings, generic field, and post-market safety data with primary citations.
Trazodone Global Regulatory Status: FDA Approval, International Labels, and Post-Market Safety
A complete review of trazodone's regulatory history across FDA, EMA, and global agencies, including approval timelines, labeling updates, and post-market safety surveillance data.
Trazodone Label Updates 2020-2026: FDA Safety Revisions, Boxed Warnings, and Post-Market Changes
A comprehensive review of trazodone FDA label updates from 2020 through 2026, covering revised warnings, post-market safety data, boxed warning modifications, and clinical guidance changes.
Trazodone Pipeline and Next-Gen Formulations: What Clinicians Should Know
A clinical review of trazodone's regulatory history, current label, post-market safety data, pipeline formulations, and future directions for this widely prescribed SARI antidepressant.
Trazodone: EMA vs FDA Regulatory Approach
A detailed comparison of how the FDA and EMA regulate trazodone, covering approved indications, labeling differences, safety warnings, and post-market surveillance strategies.